Acurx Pharmaceuticals, Inc. Current Assets
Acurx Pharmaceuticals, Inc. (ACXP) had Current Assets of $6.16 million as of 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-08-11
- 2025-06-30: Assets, Current $6.16M.
- 2025-03-31: Assets, Current $4.81M.
- 2024-12-31: Assets, Current $3.86M.
- 2024-09-30: Assets, Current $5.98M.
| Period end | Assets, Current |
|---|---|
| 2025-06-30 | $6.16M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.81M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.86M 10-Q · filed 2025-08-11 |
| 2024-09-30 | $5.98M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $7.71M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $7.16M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $9.24M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $7.39M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $9.38M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $10.95M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $9.21M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $13.25M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |